Sign Up to like & get
recommendations!
2
Published in 2022 at "Toxins"
DOI: 10.3390/toxins14030210
Abstract: Sodium–glucose cotransporter (SGLT) inhibitors are a class of oral hypoglycemic agents, which, in recent years, have been shown to improve renal and cardiovascular outcomes in patients with diabetic and non-diabetic chronic kidney disease. There remains…
read more here.
Keywords:
gut;
inhibitor production;
sglt inhibitor;
effects sglt ... See more keywords